Topics
July/August 2016 | What's New On The Anti-pdgf Front?
An Oral Drug for Treatment of AMD?
The potential for this proposed treatment option could be significant for many patients and their caregivers.
Carl C. Awh, MD
June 30, 2026
Exonate Appoints Olav Hellebø as CEO
FDA Grants Priority Review to Genentech's Supplemental BLA for Enspryng in Thyroid Eye Disease
June 29, 2026
4DMT Completes Enrollment in Second Phase 3 Trial of 4D-150 for Wet AMD
Lumibird Medical Introduces Wireless Integre LIO System for Retinal Laser Procedures
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
